Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

National Research (NRC) Net Income towards Common Stockholders (2016 - 2025)

Historic Net Income towards Common Stockholders for National Research (NRC) over the last 16 years, with Q3 2025 value amounting to $4.1 million.

  • National Research's Net Income towards Common Stockholders fell 2753.16% to $4.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.4 million, marking a year-over-year decrease of 3972.89%. This contributed to the annual value of $24.8 million for FY2024, which is 2015.79% down from last year.
  • According to the latest figures from Q3 2025, National Research's Net Income towards Common Stockholders is $4.1 million, which was down 2753.16% from -$106000.0 recorded in Q2 2025.
  • National Research's 5-year Net Income towards Common Stockholders high stood at $9.7 million for Q3 2021, and its period low was -$106000.0 during Q2 2025.
  • Moreover, its 5-year median value for Net Income towards Common Stockholders was $7.3 million (2023), whereas its average is $7.1 million.
  • Its Net Income towards Common Stockholders has fluctuated over the past 5 years, first surged by 2785.73% in 2023, then tumbled by 10171.66% in 2025.
  • National Research's Net Income towards Common Stockholders (Quarter) stood at $9.6 million in 2021, then decreased by 27.52% to $7.0 million in 2022, then rose by 27.86% to $8.9 million in 2023, then decreased by 26.52% to $6.6 million in 2024, then plummeted by 37.16% to $4.1 million in 2025.
  • Its Net Income towards Common Stockholders was $4.1 million in Q3 2025, compared to -$106000.0 in Q2 2025 and $5.8 million in Q1 2025.